- Initiated PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of MDD – - Received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy ...

- U.S. Food and Drug Administration (“FDA”) Commissioner identifies psychedelic drug development as a top agency priority in an effort to address unmet needs in mental health - - Calls for FDA to be ...

Psychedelic stocks surged in premarket trading on Monday after President Donald Trump signed an executive order on Saturday to dramatically accelerate research into, and expand patient access to ...

Psychedelics company Cybin Inc. CYBN announced an overnight marketed public offering of its units and confirmed its set pricing on an aggregate 24,264,706 Cybin units, at $0.34 each, for aggregate ...

Cybin Inc. CYBN announced that it has received approval from an independent ethics committee in the Netherlands to begin the first in-human dosing of its proprietary deuterated N, N-dimethyltryptamine ...

- Combination creates the largest intellectual property portfolio in the psychedelic drug development sector with 28 patents granted and 158 patents pending - - Creates strong synergies by combining ...

Cybin has put out more data on its psychedelic treatment for depression, presenting findings from a phase 2 trial that suggest there may be benefits to repeat administration but not to increasing the ...

TORONTO, December 19, 2025--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by ...

Despite how common depression is, reports indicate that over half of those who take antidepressants to manage this mental health illness do not experience relief. According to research from the ...

Buying undiscovered gems is a great way to get exposure to upside. Psychedelic medicines are highly promising treatments for mental illnesses, but they're nowhere near being moneymakers ... yet. As ...

For millennia, people have loved many varieties of mushrooms for their delicious utility in culinary pursuits. But in modern times, the use of psychedelic mushrooms has largely been relegated to the ...

Psilocybin and other psychedelic drugs may still be federally prohibited, Schedule-1 Controlled substances, ostensibly with no accepted medical use. But gold-standard research demonstrating the ...